REGULATORY ALERT – AUSTRALIA
How your Singapore HSA Approval Can Fast-Track TGA Registration in Australia
If your medical device is registered with Singapore’s Health Sciences Authority, you already have most of what you need for Australian ARTG inclusion.
Singapore-based manufacturers and Asia-Pacific distributors
If your device is registered with Singapore’s Health Sciences Authority (HSA), you’re ahead of most overseas manufacturers when it comes to entering the Australian market. Since September 2022, the TGA has recognised HSA as a Comparable Overseas Regulator (COR). This means your Singapore registration isn’t just useful background. It’s formal regulatory evidence that the TGA will accept to support your Australian ARTG application.
This guide explains exactly how that pathway works, which devices are eligible, what you still need to provide, and how the process fits together in practice.
Why HSA Approval Matters for Australian Market Entry
Singapore’s position as the premier medical device regulatory hub in the Asia-Pacific region means that manufacturers who have already navigated HSA registration have typically built the kind of technical and clinical documentation package that translates directly into what the TGA needs.
More importantly, the TGA’s recognition of Singapore HSA as a COR means that HSA approval is now treated as formal conformity assessment evidence. You are not starting the Australian application from zero. The TGA is, in effect, relying on the evaluation work HSA already did.
legal basis
TThe TGA’s recognition of HSA as a Comparable Overseas Regulator was implemented through the Therapeutic Goods (Medical Devices – Information that Must Accompany Application for Inclusion) Amendment (Singapore) Determination 2022. HSA joined the existing group of TGA CORs including the EU, US FDA, Health Canada and Japan PMDA/MHLW as a recognised reference authority for medical device conformity assessment in Australia.
Which Devices Are Eligible?
Not every HSA-registered device qualifies for the abridged TGA pathway. The TGA’s recognition applies to the following device classes:
Medical devices:
– Singapore HSA Class B → supports TGA Class IIa applications
– Singapore HSA Class C → supports TGA Class IIb applications
– Singapore HSA Class D → supports TGA Class III applications
IVDs (In Vitro Diagnostics):
– Singapore Class B IVD → supports TGA Class 2 IVD applications
– Singapore Class C IVD → supports TGA Class 3 IVD applications
Class A devices in Singapore are generally exempt from HSA registration. If your device is Class A, the HSA COR pathway is not available but alternative COR evidence such as EU CE marking, FDA clearance, Health Canada approval, or MDSAP certification may still apply.
⚠ Watch out
Your HSA registration must be current at the time of the TGA application. An expired or suspended registration cannot be used as COR evidence, even if the device was previously approved. If your HSA registration is approaching its renewal date, renew it before commencing your Australian application.
What the Abridged Pathway Means in Practice?
Under the standard TGA application process, a manufacturer submits a full conformity assessment package, which for higher-risk devices can run to hundreds of pages of technical, clinical and quality documentation.
Under the abridged pathway using HSA as COR evidence, the documentation burden is substantially reduced. Rather than compiling a full dossier from scratch, you provide the following:
Evidence of your Singapore HSA registration
An extract or copy of the entry in the Singapore Register of Health Products for your device. This is the single document that triggers the abridged pathway. The entry must show the current registered product, its classification, intended use and manufacturer details.
Australian Declaration of Conformity
A signed declaration that your device meets the Australian Essential Principles. The TGA provides templates — most manufacturers use the Clause 1.8 template if they hold full quality assurance certification. This is an Australia-specific document and cannot be substituted with the Singapore equivalent.
Essential Principles Checklist
Documents compliance with each applicable Essential Principle under Schedule 1 of the Therapeutic Goods (Medical Devices) Regulations 2002. If you hold a compliant GSPR or ERC from an EU technical file, these can generally be adapted rather than prepared from scratch.
Australian labelling and Instructions for Use
Existing labelling must be reviewed and adapted for Australian requirements. At minimum, your Australian Sponsor’s name and address must appear on the label or outer packaging. ARTG-specific wording requirements also apply. This is commonly the most time-consuming part of preparing for an Australian submission.
Practical tip
Manufacturers who treat labelling as an afterthought typically cause their own delays. The labelling review and update process (particularly for manufacturers with long print lead times or complex supply chains) should start at the same time as, or even before, the rest of the application is prepared.
You Still Need an Australian Sponsor
Supplying a medical device in Australia without an appointed Sponsor and valid ARTG inclusion is a breacThis is the step that surprises many Singapore-based manufacturers.
Regardless of how strong your global regulatory position is, you cannot submit an ARTG application in Australia unless your organisation is an Australian entity conducting business in Australia. If you are incorporated in Singapore, even with a strong HSA registration and excellent technical documentation, you must appoint an Australian Sponsor before any application can be lodged.
The Australian Sponsor is an Australian-registered entity that takes on the legal regulatory responsibilities for your device on the Australian market. Their name and Australian address appears on your product labelling, and they become the TGA’s primary point of contact for the life of the registration.
What the Sponsor does on your behalf
- Submits the ARTG inclusion application to the TGA through the TGA Business Services (TBS) portal
- Submits Manufacturer Evidence (your HSA registration extract) to the TGA
- Manages all TGA correspondence during evaluation, including any requests for additional information
- Handles post-market obligations including adverse event reporting, labelling updates and ARTG maintenance
- Remains the TGA’s point of contact for recalls, market actions and compliance queries throughout the product’s life in Australia
Independent Sponsor vs distributor as Sponsor
Many manufacturers entering Australia for the first time consider appointing their Australian distributor as Sponsor. This works, but it ties your ARTG registration to that commercial relationship. If your distribution arrangements change, which they often do, changing Sponsors requires a formal TGA transfer process.
An independent professional Sponsor keeps your regulatory position separate from your commercial arrangements. You can appoint multiple distributors, change distribution partners, or adjust your go-to-market strategy without affecting your ARTG listings. For manufacturers planning a serious long-term presence in Australia, independent sponsorship is almost always the better structural choice.
The Singapore-to-Australia Pathway: Step by Step
For a Singapore-registered Class B or C medical device, the practical process looks like this:
Step 1: Appoint an Australian Sponsor
Your Sponsor needs to be registered in the TGA Business Services portal before any application can be lodged. Allow one to two weeks for this.
Step 2: Confirm eligibility
Verify that your HSA registration is current and that the product details — intended use, classification, manufacturer — match what you intend to register in Australia. Discrepancies between the Australian application and the HSA registration will need to be resolved before submission.
Step 3: Review and update Australian labelling
Your product labelling and IFU must include your Australian Sponsor’s name and address. Assess what changes are needed and plan the print timeline accordingly.
Step 4: Appoint an Australian Sponsor
The Australian Declaration of Conformity and Essential Principles Checklist are prepared. These are not the same as their Singapore counterparts, but the underlying technical information carries across.
Step 5: Lodge the ARTG application
Your Sponsor submits the application via the TBS portal. The HSA registration extract is uploaded as Manufacturer Evidence. TGA application fees are paid at lodgement.
Step 6: TGA Evaluation
The TGA reviews the application. Your Sponsor manages any TGA queries. For abridged applications using COR evidence, evaluation is generally more straightforward than for full applications, though actual processing times vary.
Step 7: ARTG Inclusion
Once approved, your device is listed on the ARTG with your Sponsor’s details. Your product can be legally marketed and supplied in Australia.
How Long Does It Take?
The TGA aims to complete initial reviews within 20 working days. If additional information is requested, the TGA aims to provide a final decision within 180 working days.
Realistic timeline: three to six months for a Class IIa device, assuming documentation is complete and minimal Section 41JA requests for further information are issued.
Class IIb devices typically take longer due to additional documentation requirements. Manufacturers who engage an Australian Sponsor early, before documentation preparation begins, consistently move faster because Sponsor and manufacturer can work in parallel.
practical tip
The TGA publishes current processing times on its Sponsor Information Dashboard (SID). These fluctuate throughout the year. Your Sponsor can advise on realistic current expectations based on live TGA data at the time of submission
Common Issues to Look For
Intended use differences. If your device is registered in Singapore with a slightly different intended use or indications than what you want on the Australian ARTG, this needs to be reconciled before submission. The Australian application must reflect what HSA actually approved and any expansion of indications will require additional supporting evidence.
Classification differences. Australia and Singapore use broadly similar risk-based classification frameworks, but the rules are not identical. Confirm your Australian classification before submission. A Class B device in Singapore is not automatically Class IIa in Australia.
HSA registration currency. The TGA requires your HSA registration to be current at the time of application. Plan accordingly if your registration is approaching renewal.
Post-market differences. Even after ARTG inclusion, Australian post-market obligations differ from Singapore’s. Your Sponsor will manage these, but the manufacturer needs to be aware of Australian adverse event reporting timeframes and how these interact with any global pharmacovigilance system.
Not sure if your product needs TGA registration?
The TGA provides an online ‘Is my product a medical device?’ tool, and Practical RA can provide an assessment as part of initial discussions — at no charge.
Frequently Asked Questions
practical tip
If you are a Singapore-based manufacturer or Asia-Pacific distributor evaluating Australian market entry, your first step is confirming that your HSA registration is current and identifying an Australian Sponsor. These two steps can run in parallel and are the foundation everything else builds on.
Why Manufacturers Choose Practical RA
A Boutique Firm. Local TGA Experience.
Unlike large multinational regulatory consultancies, Practical RA operates as a specialist boutique with senior-led work, direct access to our team, and active TGA relationships built over years.
Australian-based team
Our Melbourne office engages directly with the TGA. We’re not routing your matter through an overseas hub so your submission is managed locally.
Fixed-fee, no surprises
Every engagement is quoted at a fixed fee after scoping. You know the cost before you commit. No timesheets, no scope creep invoices.
End-to-end managed
We handle everything from initial ARTG audit through to live AusUDID records. You don’t need to learn the TGA portal or data dictionary.
Why choose us
Ready to discuss your Australian Sponsor options?
If you’re evaluating Australian Sponsor options, we’re happy to have an initial conversation at no charge
✓ Response within 1 business day · All enquiries treated confidentially · No commitment required
✉ Or contact Tara directly: tara@practicalra.com
Key Takeaways
– The TGA has recognised Singapore’s HSA as a Comparable Overseas Regulator since September 2022 — HSA-registered devices are eligible for the abridged TGA application pathway
– Eligible classes are Singapore Class B, C and D medical devices and Class B and C IVDs — mapping to TGA Class IIa, IIb, Class III and IVD Classes 2 and 3
– The HSA registration extract is submitted as Manufacturer Evidence, replacing the need to compile a full conformity assessment dossier from scratch
– You still need an Australian Sponsor regardless of your HSA registration status — this is a mandatory legal requirement under the Therapeutic Goods Act 1989
– Australian labelling must be updated to include the Sponsor’s name and address before supply can commence — plan the print timeline early
– Realistic timeline from Sponsor appointment to ARTG inclusion is four to eight months for a Class IIa equivalent device
practical tip
If you are working with, or planning to work with, multiple Australian distributors, or if you anticipate your distribution arrangements may change, an independent professional Sponsor is almost always the better structural choice. The cost of changing Sponsors after the fact, including relabelling and TGA transfer administration, generally exceeds the cost of getting the structure right from the start.
Leave a Reply
You must be logged in to post a comment.